Our experts explore the hottest topics and controversies in intellectual property law
In this podcast series, Australian partners Rebekah Gay and Emma Iles explore a variety of topics, issues and areas of intellectual property law.
LATEST EPISODE – PATENTING FOR THE ENERGY TRANSITION
In episode 6, Rebekah and Emma are joined by Andrew Wells from Herbert Smith Freehills’ London office to take a look at a recent report from the European Patent Office and the International Energy Agency, which uses data relating to patent filings to map some fascinating trends in innovation in the clean energy space.
EPISODE 5 – A GREEN LIGHT FOR GREENPEACE
In episode 5, Emma and Rebekah are joined by their colleague, Aaron Hayward, to talk about the recent decision on copyright and trade mark infringement in proceedings initiated by AGL over a Greenpeace advertising campaign targeting AGL.
EPISODE 4 – EMMA AND REBEKAH TALK IP: UNPACKING THE PATENT BOX
In episode 4, Emma and Rebekah are joined by corporate tax expert, Michael Anderson of Greenwoods & Herbert Smith Freehills to talk about the proposed patent box regime announced in the recent Federal budget, and unpack what is going on behind the proposal.
EPISODE 3 – EMMA AND REBEKAH TALK IP: CHEESE, OLIVES AND HONEY: A STICKY SITUATION FOR “GEOGRAPHICAL INDICATIONS”
In episode 3, Emma and Rebekah talk “geographical indications” – what are they, why are they hitting the news, and what has it all got to do with cheese and honey?
EPISODE 2 – EMMA AND REBEKAH TALK IP: "WE'RE NOT GONNA TAKE IT" AND COPYRIGHT LAW
This episode will explore the recent copyright case involving Clive Palmer and his use of the Twisted Sister hit “We’re Not Gonna Take It” including what arguments were raised in defence of the copyright infringement claim and the nature of the final remedies.
Click here to read our IP team’s overview of this case.
EPISODE 1 – EMMA AND REBEKAH TALK IP: COVID-19 VACCINES AND PATENT WAIVER RIGHTS
This episode will explore issues around the possible patent waiver of IP rights related to COVID-19 vaccines by the WTO including what is actually being proposed and the complexities in providing equitable access to the vaccines.